Tissue Regenix Group (LSE:TRX) EV-to-Revenue : 2.23 (As of Jun. 06, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Tissue Regenix Group's enterprise value is £52.06 Mil. Tissue Regenix Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £23.33 Mil. Therefore, Tissue Regenix Group's EV-to-Revenue for today is 2.23.

The historical rank and industry rank for Tissue Regenix Group's EV-to-Revenue or its related term are showing as below:

LSE:TRX' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.22 Med: 8.56 Max: 29490.17
Current: 2.24

During the past 13 years, the highest EV-to-Revenue of Tissue Regenix Group was 29490.17. The lowest was 0.22. And the median was 8.56.

LSE:TRX's EV-to-Revenue is ranked better than
78.32% of 1038 companies
in the Biotechnology industry
Industry Median: 7.985 vs LSE:TRX: 2.24

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-06), Tissue Regenix Group's stock price is £0.685. Tissue Regenix Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.33. Therefore, Tissue Regenix Group's PS Ratio for today is 2.06.

Tissue Regenix Group EV-to-Revenue Historical Data

The historical data trend for Tissue Regenix Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group EV-to-Revenue Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

0.84

2.70

2.50

2.09

1.71

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															2.50	-	2.09	-	1.71

Competitive Comparison of Tissue Regenix Group's EV-to-Revenue

For the Biotechnology subindustry, Tissue Regenix Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Regenix Group's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's EV-to-Revenue falls into.

Tissue Regenix Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Tissue Regenix Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	52.059	/	23.328
	=	2.23

Tissue Regenix Group's current Enterprise Value is £52.06 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tissue Regenix Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £23.33 Mil.

Tissue Regenix Group (LSE:TRX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Tissue Regenix Group's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.685	/	0.332
	=	2.06

Tissue Regenix Group's share price for today is £0.685.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was £0.33.

Tissue Regenix Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.